Lunsumio Velo Injection
Product Images NDC 50242-201

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lunsumio Velo (NDC 50242-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Lunsumio 01)

A line graph depicting the concentration of Mosunetuzumab (µg/mL) over time in days on a logarithmic scale. The graph shows a median concentration curve with periodic fluctuations and a shaded area representing the 90th percentile prediction interval across a time span of 0 to 168 days.*

FDA Label Image

Principal Display Panel (5 mg/0.5 mL Vial Carton)

Label for Lunsumio Velo (mosunetuzumab-axgb) Injection, 5 mg/0.5 mL subcutaneous single-dose vial. The label highlights subcutaneous use, discard of unused portion, and dispensing of a medication guide. Manufactured by Genentech, Inc. The label includes the NDC 50242-177-01 and indicates one vial per package.*

FDA Label Image

Principal Display Panel (45 mg/mL Vial Carton)

Label for Lunsumio Velo (mosunetuzumab-axgb) Injection, 45 mg/mL strength. This single-dose vial is intended for subcutaneous use only. The label advises discarding unused portions and dispensing the enclosed Medication Guide to patients. Manufactured by Genentech, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.